Research Topics
| M I FielSummaryAffiliation: Mount Sinai School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantationM Isabel Fiel
The Lillian and Henry M Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, Mount Sinai School of Medicine, New York, New York, USA
Curr Opin Organ Transplant 17:287-92. 2012..Its pathogenesis is poorly understood but this entity appears to be a variant of rejection. Herein, we review recent clinical reports of patients developing PCH...
Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantationM I Fiel
The Lillian and Henry M Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York 10029, USA
Transpl Infect Dis 10:184-9. 2008..Infrequently, hepatitis C (HCV) appears to be the cause of hepatic granulomas. Interferon therapy for HCV has been increasingly associated with the development of sarcoidosis...
Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver diseaseM Isabel Fiel
The Lillian and Henry M Stratton Hans Popper Department of Pathology, Mount Sinai School of Medicine, New York, New York 10029, USA
Clin Gastroenterol Hepatol 6:926-33. 2008..The decision to perform combined transplantation as opposed to an isolated intestinal transplant is based on the presence of hyperbilirubinemia, portal hypertension, and advanced hepatic fibrosis...
Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virusM Isabel Fiel
Lillian and Henry M Stratton Hans Popper Department of Pathology, Mount Sinai Medical Center, New York, NY 10029, USA
Liver Transpl 14:861-71. 2008..Treatment by optimization of immunosuppression without the use of corticosteroids appears effective. The development of PCH in the setting of recurrent HCV is a negative prognostic factor for patient outcome and allograft failure...
Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantationM Isabel Fiel
Lillian and Henry M Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, NY 10029, USA
J Gastrointest Surg 13:1717-23. 2009....
Pathology of chronic hepatitis B and chronic hepatitis CM Isabel Fiel
The Lillian and Henry M Stratton Hans Popper Department of Pathology, The Mount Sinai Medical Center, Mount Sinai School of Medicine, Box 1194, 1468 Madison Avenue, New York, NY 10029, USA
Clin Liver Dis 14:555-75. 2010..The salient histologic features are elucidated in an attempt to provide the clinician with an understanding of the basic histopathology underlying chronic HCV and HBV...
Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explantStephen C Ward
Lillian and Henry M Stratton Hans Popper Department of Pathology, Recanati Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY 10029, USA
Liver Transpl 15:1826-33. 2009..The association of significant plasma cell infiltrates in native livers of HCV patients developing PCH suggests that some patients may have a predisposition to developing PCH...
Image segmentation of liver fibrosisH S Wu
Department of Pathology, Box 1194, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA
J Microsc 231:70-80. 2008..The proposed algorithm has been applied to quantify the development of progressive fibrosis and its possible regression in liver biopsy specimens from patients with parenteral-induced liver injury undergoing intestinal transplantation...
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosisJosep M Llovet
Mount Sinai Liver Cancer Program, Department of Medicine, Mount Sinai School of Medicine, New York 10029, USA
Gastroenterology 131:1758-67. 2006..Small liver nodules approximately 2 cm are difficult to characterize by radiologic or pathologic examination. Our aim was to identify a molecular signature to diagnose early hepatocellular carcinoma (HCC)...
Identification of ultrastructural changes in liver allografts of patients experiencing primary nonfunctionA Lawal
Department of Liver Diseases and Transplantation, The Mount Sinai Medical Center, New York, New York 10029, USA
Transplant Proc 37:4339-42. 2005..17). CONCLUSION: Liver allografts from patients suffering from PNF can have mitochondrial ultrastructural changes on preperfusion biopsies...
Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case seriesHui Hui Tan
Division of Liver Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
Liver Transpl 15:634-9. 2009..Treatment of rejection or plasma cell hepatitis in this setting should be undertaken in a timely and aggressive fashion to prevent chronic ductopenic rejection...
Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markersMyron Schwartz
Mount Sinai Liver Cancer Program, Department of Surgery, Recanati Miller Transplantation Institute, Division of Liver Disease, New York, NY 10029, USA
J Hepatol 49:581-8. 2008..This study uses molecular data to identify a subgroup of patients who, despite having hepatocellular carcinoma beyond Milan criteria, have favorable outcomes...
Liver transplantation is possible in some patients with liver metastasis of colon cancerO Uskudar
Division of Liver Diseases, The Mount Sinai Hospital, Recanati Miller Transplantation Institute, New York, NY, USA
Transplant Proc 43:2070-4. 2011..This report demonstrates that liver transplantation may be an option in selected patients with colorectal cancer liver metastases that have been well treated...
Nevirapine-induced stevens johnson-syndrome and fulminant hepatic failure requiring liver transplantationJ Jao
Department of Medicine, Mount Sinai Hospital and School of Medicine, New York, NY, USA
Am J Transplant 10:1713-6. 2010..On follow-up 2 years later, she remains in good health with an undetectable viral load on an efavirenz-based regimen of HAART. To our knowledge, this is the first report of successful liver transplantation following SJS and FHF...
Restoration of distorted colour microscopic images from transverse chromatic aberration of imperfect lensesH S Wu
Department of Pathology, Mount Sinai School of Medicine, New York, NY 10029, USA
J Microsc 241:125-31. 2011..Results of real microscopic images are provided. The restored image and the original are compared both visually and quantitatively in terms of the estimated entropies measured for the degree of concentrations using vector distributions...
Pegylated interferon-induced immune-mediated hepatitis post-liver transplantationNickolas Kontorinis
Division of Liver Diseases, Recanati Miller Transplantation Institute, New York, NY 10029, USA
Liver Transpl 12:827-30. 2006..We hypothesize that pegylated interferon triggered a severe form of immune-mediated hepatitis...
Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantationNeeraj Saraf
Mount Sinai Medical Center Division of Liver Diseases, New York, NY 10029, USA
Liver Transpl 13:913-7. 2007..To our knowledge, this is the earliest reported case of histological recurrence of HCV after LT. It illustrates the importance of older donor and recipient age in the same patient as cofactors for early HCV recurrence and poor outcome...
Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirinCarmen M Stanca
Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
Transplantation 84:180-6. 2007..We examined the incidence of chronic ductopenic rejection (CR) in patients receiving pegylated interferon alfa-2a and ribavirin (PEG) to treat recurrent HCV...
Factors associated with persistent thrombocytopenia after liver transplantationC M Stanca
Division of Liver Diseases, Mount Sinai Medical Center, New York, New York 10029, USA
Transplant Proc 42:1769-73. 2010..Identifying risk factors associated with persistent post- LT thrombocytopenia may provide important information about its pathogenesis...
Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infectionS A Gonzalez
Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, NY 10065 4896, USA
J Viral Hepat 15:331-8. 2008..Further studies are needed to assess whether decreased IFN-gamma secretion by HCV-specific CD4+ cells may account for accelerated fibrogenesis in these patients...
Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcomeMichal Carmiel-Haggai
Recanati/Miller Transplantation Institute, Mount Sinai Hospital, The Mount Sinai School of Medicine, PO Box 1504, New York, NY 10029-6574, USA
Liver Transpl 11:1567-73. 2005..Patients experiencing early graft failure due to accelerated forms of HCV should not be denied re-LT with the expectation that a similar disease course will occur after re-LT...
Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone useKaiser Raja
Division of Liver Diseases, Recanati Miller Transplantation Institute, The Mount Sinai Medical Center, New York, NewYork 10029, USA
Semin Liver Dis 29:423-8. 2009..The clinical manifestations of amiodarone-induced hepatotoxicity and the mechanism of toxicity are also discussed...
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donorsThomas D Schiano
The Recanati/Miller Transplantation Institute, The Mount Sinai Hospital, New York, NY, USA
Hepatology 42:1420-8. 2005..The trend toward a greater initial viral load decrease in patients with LD grafts and the significantly sharper increase suggest that the liver plays a predominant role in both HCV clearance and replication...
De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literatureAnca Croitoru
The Lillian and Henry M Stratton-Hans Popper Department of Pathology, The Mount Sinai Medical Center, One Gustave L Levy Place, New York, New York 10029, USA
Dig Dis Sci 51:1780-2. 2006
Hepatocellular carcinoma associated with an atypical presentation of Wilson's diseaseRuliang Xu
The Lillian and Henry M. Stratton-Hans Popper Department of Pathology, The Mount Sinai Medical Center, New York, New York 10029, USA
Semin Liver Dis 27:122-7. 2007
Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort studyDaniel S Fierer
Division of Infectious Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
J Infect Dis 198:683-6. 2008..No cause of liver damage other than acute HCV infection was identified. The specific pathways leading to periportal fibrosis in HIV-infected men with newly acquired HCV infection require investigation...
Recurrent hepatic sarcoidosis post-liver transplantation manifesting with severe hypercalcemia: a case report and review of the literatureCem Cengiz
Recanati/Miller Transplantation Institute, The Mount Sinai School of Medicine, PO Box 1504, New York, NY 10029-6574, USA
Liver Transpl 11:1611-4. 2005..To date, there has been no report in the literature of symptomatic recurrence of hepatic sarcoidosis following orthotopic liver transplantation...
Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patientsP Wilfredo Canchis
Center for the Study of Hepatitis C, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
J Acquir Immune Defic Syndr 37:1125-31. 2004..09 cell/HPF) and monoinfected patients (0.45 +/- 0.08 cell/HPF). In conclusion, HIV coinfection is associated with fewer portal CD4 cells and increased lobular lymphocyte apoptosis that may impact on the natural history of HCV infection...
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivoPippa Newell
Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029, USA
J Hepatol 51:725-33. 2009..We investigated the molecular alterations of the Ras pathway in HCC and the antineoplastic effects of sorafenib in combination with rapamycin, an inhibitor of mTOR pathway, in experimental models...
Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytesRifaat Safadi
Division of Liver Diseases, The Mount Sinai School of Medicine, New York, New York, USA
Gastroenterology 127:870-82. 2004..In this model, fibrosis may be a CD8+ T-cell-mediated disease that is attenuated by rIL-10...
Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expressionMeena B Bansal
Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA
J Hepatol 42:548-56. 2005..Because studies suggest matrix metalloproteinase-2 (MMP-2) may promote liver injury, we examined whether IL-6 exerted its protective effects via regulation of MMP-2...
Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis?Carmen M Stanca
Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
Semin Liver Dis 25:364-70. 2005
Diagnosis of 6 mercaptopurine hepatotoxicity post liver transplantation utilizing metabolite assaysNickolas Kontorinis
Recanati Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY, USA
Am J Transplant 4:1539-42. 2004..Monitoring of 6 MP metabolite levels in addition to TPMT allele testing is useful to prevent 6 MP toxicity and to help guide therapy...
Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activationFeng Hong
Mount Sinai School of Medicine, New York, NY 10029, USA
Hepatology 49:2055-67. 2009..The availability of small molecule inhibitors of CXCR4 make this receptor an appealing target for antifibrotic approaches...
Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIVThomas D Schiano
The Recanati Miller Transplantation Institute, and the Division of Liver Diseases, Department of Medicine, The Mount Sinai Medical Center, New York, New York 10029, USA
Am J Gastroenterol 102:2536-40. 2007..Nodular regenerative hyperplasia (NRH), another cause of noncirrhotic portal hypertension, has also been recently described in HIV patients initially diagnosed as having cryptogenic liver disease...
Liver pathology in obesityArief Suriawinata
Dartmouth Hitchcock Medical Center, Department of Pathology, One Medical Center Drive, Lebanon, NH 03756, USA
Semin Liver Dis 24:363-70. 2004..This article will discuss obesity-related liver diseases, focusing on pathologic features in liver biopsies from obese patients, obesity-related hepatocellular carcinoma, and the effect of weight loss treatment on histopathology...
Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinomaIgor Dvorchik
Thomas E Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213 3236, USA
Liver Transpl 14:443-50. 2008..Incorporation of these molecular markers of tumor progression could help resolve the ongoing conundrum of organ allocation for patients with HCC...
